Dissemination of pediatric information resulting from pediatric studies done pursuant to FDAAA
Similar Posts
RIGIDRX may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use RIGIDRX, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Fromi USA Recalls Brie Royal Faucon 1kg Because of Possible Health Risk
FROMI USA of New York, NY is recalling 12 Cases of Brie Royal Faucon 1kg, because they have the potential to be contaminated with Listeria monocytogenesShilpa Medicare Limited – 11/21/2025
Shilpa Medicare Limited – 11/21/2025. Country: India. Record Type: 483Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Endo, Inc. (OTCQX: NDOI) (“Endo”) announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling.Blood Products Administration Set Recall: Fresenius Kabi Removes Large Volume Pump Blood Products Administration Sets due to Incorrect Assembly
Blood Products Administration Sets recalled due to incorrect assembly. Use may lead to administration of unfiltered blood or delays in therapy.Malaria: Developing Drugs for Treatment
Malaria: Developing Drugs for Treatment